4
Clinical Trials associated with Allogeneic Adipose-derived Stem Cells(Anterogen)A Phase 1 Clinical Study to Evaluate the Safety of Allogeneic Adipose-derived Stem Cells in the Subjects With Crohn's Disease
This is a phase I study to evaluate the safety of ALLO-ASC-CD for the treatment of crohn' disease. ALLO-ASC-CD is intravenous infusion containing allogenic adipose-derived mesenchymal stem cells.
A Multi-center, Randomized, Placebo-controlled, Double-blind, Parallel-group, Phase I/II Clinical Study to Evaluate Safety and Efficacy of Allogeneic Adipose-derived Stem Cells for the Treatment of Lateral Epicondylitis
The objective of this study is to evaluate the safety and efficacy of allogeneic adipose-derived stem cells (ALLO-ASC) in patients with lateral epicondylitis.
A Phase I dose escalation clinical study to evaluate the safety and efficacy of ALLO-ASC(Allogenic adipose-derived stem cells) in the patients with Crohn's fistula.
100 Clinical Results associated with Allogeneic Adipose-derived Stem Cells(Anterogen)
100 Translational Medicine associated with Allogeneic Adipose-derived Stem Cells(Anterogen)
100 Patents (Medical) associated with Allogeneic Adipose-derived Stem Cells(Anterogen)
100 Deals associated with Allogeneic Adipose-derived Stem Cells(Anterogen)